Regarding neonatal outcomes, data from the German COVID-19 registry (CRONOS) showed an almost five-fold increased risk of adverse neonatal outcomes in mothers with GDM treated with insulin with a normal BMI. The gene discussed is INS; the disease is gestational diabetes.